$RYET

Ruanyun Edai Technology Inc.

No enriched coverage for $RYET in the last 7 days.

No SEC Form 4 filings for $RYET in the last 30 days.

See all $RYET insider activity →

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Ruanyun Edai Technology (RYET) and BioNexus Gene Lab (BGLC) signed an agreement for an exclusive license of RYET's Cogni AI platform in Malaysia's healthcare sector. RYET will receive a 10% royalty and 560,000 BGLC shares. The deal aligns with Malaysia's healthcare digitalization efforts, though neither company is part of government programs. The license term is up to 20 years, with BGLC leading local implementation. The transaction is subject to closing conditions and has not yet closed.

RYET sentiment & insider activity

Recent RYET coverage spans financial news, earnings and corporate actions.

What's driving RYET

AlphAI scores every news story that mentions RYET with an AI model for sentiment and relevance, and aggregates insider trades from Ruanyun Edai Technology Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RYET

Score

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

Ruanyun Edai Technology (RYET) and BioNexus Gene Lab (BGLC) signed an agreement for an exclusive license of RYET's Cogni AI platform in Malaysia's healthcare sector. RYET will receive a 10% royalty and 560,000 BGLC shares. The deal aligns with Malaysia's healthcare digitalization efforts, though neither company is part of government programs. The license term is up to 20 years, with BGLC leading local implementation. The transaction is subject to closing conditions and has not yet closed.

Ruanyun Announces Preliminary Unaudited First-Half Fiscal 2027 Revenue in the Range of US$9.3 Million to US$9.5 Million

Ruanyun Edai Technology Inc. (RYET) expects preliminary unaudited revenue of $9.3M-$9.5M for the first half of fiscal 2027, more than double the $4.11M recorded in the same period of fiscal 2025. Campus services are expected to contribute $5.0M-$5.2M, while other segments include smart-campus infrastructure and AI applications.

Ruanyun Edai Technology Inc. (RYET): Financial results for FY2026

Ruanyun Edai Technology Inc. (RYET) furnished an SEC Form 6-K — earnings release. EXHIBIT 99.1 Ruanyun Edai Technology Announces Fiscal 2026 Financial Results; Reports 11.9% Revenue Growth and Return to Positive Equity Campus operations and student-life services contributed $5.72 million and became the Company’s largest revenue source KUALA LUMPUR, Malaysia, A

$RYETLow

RYET Technical Analysis | RUANYUN EDAI TECHNOLOGY INC (NASDAQ:RYET)

This article provides a technical analysis of RUANYUN EDAI TECHNOLOGY INC (NASDAQ:RYET), indicating a negative outlook with an overall technical rating of 0 out of 10. The stock shows poor performance compared to the general market and its industry peers, with both short-term and long-term trends being negative. Key indicators like SMA and MACD suggest a downward trend, while Stochastics indicate it might be oversold, and ATR points to high volatility.

Related tickers